The purpose of this study is to evaluate change of cerebral glucose metabolism by donepezil therapy and to associate change of glucose metabolism and symptoms.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
24
Osaka University Hospital
Suita, Osaka, Japan
FDG-PET
Time frame: 14 weeks
Cognitive function, psychiatric symptoms, global clinical function, and burden of caregiver
Time frame: 14 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.